125 related articles for article (PubMed ID: 34871801)
1. TTF-1: A Well-Favored Addition to the Immunohistochemistry Armamentarium as a Diagnostic Marker of SEGA.
Dutta R; Sharma MC; Suri V; Sarkar C; Garg A; Suri A; Kale SS
World Neurosurg; 2022 Mar; 159():e62-e69. PubMed ID: 34871801
[TBL] [Abstract][Full Text] [Related]
2. Thyroid transcription factor-1 distinguishes subependymal giant cell astrocytoma from its mimics and supports its cell origin from the progenitor cells in the medial ganglionic eminence.
Hang JF; Hsu CY; Lin SC; Wu CC; Lee HJ; Ho DM
Mod Pathol; 2017 Mar; 30(3):318-328. PubMed ID: 27910945
[TBL] [Abstract][Full Text] [Related]
3. Subependymal giant cell astrocytoma: a lesion with activated mTOR pathway and constant expression of glutamine synthetase.
Buccoliero AM; Caporalini C; Giordano F; Mussa F; Scagnet M; Moscardi S; Baroni G; Genitori L; Taddei GL
Clin Neuropathol; 2016; 35(5):295-301. PubMed ID: 27390104
[TBL] [Abstract][Full Text] [Related]
4. Consistent nuclear expression of thyroid transcription factor 1 in subependymal giant cell astrocytomas suggests lineage-restricted histogenesis.
Hewer E; Vajtai I
Clin Neuropathol; 2015; 34(3):128-31. PubMed ID: 25669749
[TBL] [Abstract][Full Text] [Related]
5. Unique findings of subependymal giant cell astrocytoma within cortical tubers in patients with tuberous sclerosis complex: a histopathological evaluation.
Katz JS; Frankel H; Ma T; Zagzag D; Liechty B; Zeev BB; Tzadok M; Devinsky O; Weiner HL; Roth J
Childs Nerv Syst; 2017 Apr; 33(4):601-607. PubMed ID: 28074282
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical study of central neurocytoma, subependymoma, and subependymal giant cell astrocytoma.
You H; Kim YI; Im SY; Suh-Kim H; Paek SH; Park SH; Kim DG; Jung HW
J Neurooncol; 2005 Aug; 74(1):1-8. PubMed ID: 16078101
[TBL] [Abstract][Full Text] [Related]
7. BRAF V600E mutations are frequent in dysembryoplastic neuroepithelial tumors and subependymal giant cell astrocytomas.
Lee D; Cho YH; Kang SY; Yoon N; Sung CO; Suh YL
J Surg Oncol; 2015 Mar; 111(3):359-64. PubMed ID: 25346165
[TBL] [Abstract][Full Text] [Related]
8. Tuber and subependymal giant cell astrocytoma associated with tuberous sclerosis: an immunohistochemical, ultrastructural, and immunoelectron and microscopic study.
Hirose T; Scheithauer BW; Lopes MB; Gerber HA; Altermatt HJ; Hukee MJ; VandenBerg SR; Charlesworth JC
Acta Neuropathol; 1995; 90(4):387-99. PubMed ID: 8546029
[TBL] [Abstract][Full Text] [Related]
9. Subependymal giant cell astrocytoma (SEGA): Is it an astrocytoma? Morphological, immunohistochemical and ultrastructural study.
Buccoliero AM; Franchi A; Castiglione F; Gheri CF; Mussa F; Giordano F; Genitori L; Taddei GL
Neuropathology; 2009 Feb; 29(1):25-30. PubMed ID: 18564101
[TBL] [Abstract][Full Text] [Related]
10. Thyroid transcription factor-1 in primary CNS tumors.
Kristensen MH; Nielsen S; Vyberg M
Appl Immunohistochem Mol Morphol; 2011 Oct; 19(5):437-43. PubMed ID: 21325940
[TBL] [Abstract][Full Text] [Related]
11. Solitary subependymal giant cell astrocytoma incidentally found at autopsy in an elderly woman without tuberous sclerosis complex.
Takei H; Adesina AM; Powell SZ
Neuropathology; 2009 Apr; 29(2):181-6. PubMed ID: 18673443
[TBL] [Abstract][Full Text] [Related]
12. Cytologic characteristics of subependymal giant cell astrocytoma in squash smears: morphometric comparisons with gemistocytic astrocytoma and giant cell glioblastoma.
Kim SH; Lee KG; Kim TS
Acta Cytol; 2007; 51(3):375-9. PubMed ID: 17536538
[TBL] [Abstract][Full Text] [Related]
13. Cytomorphology of subependymal giant cell astrocytoma.
Altermatt HJ; Scheithauer BW
Acta Cytol; 1992; 36(2):171-5. PubMed ID: 1543002
[TBL] [Abstract][Full Text] [Related]
14. Dose-level response rates of mTor inhibition in tuberous sclerosis complex (TSC) related subependymal giant cell astrocytoma (SEGA).
Weidman DR; Pole JD; Bouffet E; Taylor MD; Bartels U
Pediatr Blood Cancer; 2015 Oct; 62(10):1754-60. PubMed ID: 25929843
[TBL] [Abstract][Full Text] [Related]
15. Biological behavior and tumorigenesis of subependymal giant cell astrocytomas.
Kim SK; Wang KC; Cho BK; Jung HW; Lee YJ; Chung YS; Lee JY; Park SH; Kim YM; Choe G; Chi JG
J Neurooncol; 2001 May; 52(3):217-25. PubMed ID: 11519851
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological treatment strategies for subependymal giant cell astrocytoma (SEGA).
Ebrahimi-Fakhari D; Franz DN
Expert Opin Pharmacother; 2020 Aug; 21(11):1329-1336. PubMed ID: 32338549
[TBL] [Abstract][Full Text] [Related]
17. Erk activation as a possible mechanism of transformation of subependymal nodule into subependymal giant cell astrocytoma.
Siedlecka M; Szlufik S; Grajkowska W; Roszkowski M; Jóźwiak J
Folia Neuropathol; 2015; 53(1):8-14. PubMed ID: 25909870
[TBL] [Abstract][Full Text] [Related]
18. Role of mTOR signaling pathway in the pathogenesis of subependymal giant cell astrocytoma - A study of 28 cases.
Kumari K; Sharma MC; Kakkar A; Malgulwar PB; Pathak P; Suri V; Sarkar C; Chandra SP; Faruq M; Gupta RK; Saran RK
Neurol India; 2016; 64(5):988-94. PubMed ID: 27625244
[TBL] [Abstract][Full Text] [Related]
19. A case of solitary subependymal giant cell astrocytoma with histopathological anaplasia and TSC2 gene alteration.
Suzuki M; Kondo A; Ogino I; Akiyama O; Fujita N; Shimizu Y; Arai H
Childs Nerv Syst; 2021 Apr; 37(4):1357-1362. PubMed ID: 32725466
[TBL] [Abstract][Full Text] [Related]
20. Experience using mTOR inhibitors for subependymal giant cell astrocytoma in tuberous sclerosis complex at a single facility.
Tomoto K; Fujimoto A; Inenaga C; Okanishi T; Imai S; Ogai M; Fukunaga A; Nakamura H; Sato K; Obana A; Masui T; Arai Y; Enoki H
BMC Neurol; 2021 Mar; 21(1):139. PubMed ID: 33784976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]